Latest Tysabri news
Enhanced Atypical Lymphocytes in Natalizumab-Treated MS
posted May 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
For patients with relapsing-remitting multiple sclerosis, natalizumab treatment is associated with enhancement of atypical lymphocytes, especially binucleated and plasmacytoid lymphocytes, according to a study published online May 8 in the International Journal of Laboratory Hematology.
Tysabri Impacts Seroconversion in John Cunningham Virus
posted January 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
For patients with John Cunningham virus (JCV), natalizumab (Tysabri) treatment affects seroconversion and JCV index values, according to a study published online Jan. 27 in Neurology: Neuroimmunology & Neuroinflammation.
Editor's Recommendations
Low Levels of Placental Growth Factor in Pregnancy Linked to Subsequent ADHD in Offspring .jpg)
Time-Restricted Eating Shows Possible Benefits for Patients With Huntington Disease 
Past Blast Exposure Tied to Long-Term Chronic Medical Diagnoses in Veterans 
Women With Cerebral Palsy Receive Less Preventive Gynecological Care 
People With ADHD Experience 50 Percent More GI Symptoms 
1 in 4 Former NFL Players Had CTE at Death in 2016 to 2021 
Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy 
Frequent TV Watching Linked to Smaller Brain Volume Monthly Specialist Briefings
Stay Connected
